Skip to main content
Fig. 3 | Journal of Neuroinflammation

Fig. 3

From: Etifoxine improves sensorimotor deficits and reduces glial activation, neuronal degeneration, and neuroinflammation in a rat model of traumatic brain injury

Fig. 3

Tapered beam walking test. Mean (+SEM) percentage of faults with the contralateral hind limb on the beam in sham-vehicle (n = 9), TBI-vehicle (n = 10), sham-EFX (n = 10), and TBI-EFX (n = 8) groups. Treatment with EFX significantly improved motor performance and coordination on day 2 post-CCI compared to vehicle treatment in TBI animals (# p < 0.05). ***p < 0.001 compared to pre-TBI; ### p < 0.001 and # p < 0.05 compared to TBI-vehicle

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094